Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
Publishing timestamp: 2024-04-24 02:16:41
Summary
Roche reported a modest uptick in first-quarter sales, with sales up 2% at constant exchange rates driven by demand for newer medicines and diagnostics. CEO confirmed the company's 2024 outlook, stating that the impact of Covid-19 on sales is largely behind them.
Sentiment: NEUTRAL
Tickers: ROG-CH,
Keywords: earnings, pharmaceuticals, business news, business, roche holding ag, biotechnology, biotech and pharmaceuticals,